BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34203748)

  • 1. Prognostic Factors, Survival Analyses and the Risk of Second Primary Cancer: A Population-Based Study on Burkitt Lymphoma/Leukemia.
    Della Rocca AM; Tonin FS; Fachi MM; Cobre AF; Ferreira VL; Leonart LP; Steffenello-Durigon G; Del Moral JAG; Lenzi L; Pontarolo R
    Diseases; 2021 Jun; 9(2):. PubMed ID: 34203748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database.
    Castillo JJ; Winer ES; Olszewski AJ
    Cancer; 2013 Oct; 119(20):3672-9. PubMed ID: 23913575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inferior prognosis of gastric involvement in patients with gastrointestinal Burkitt Lymphoma.
    Xie Y; Jia M; Shi J; Tao Y
    Cancer Med; 2020 May; 9(9):3107-3114. PubMed ID: 32160410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry.
    Burns EA; Wilson JJ; Mathur S; Kieser R; Gong Z; Hu CA; Tang CA; Petkova J; Yuen C; Mai H; Shah S; Rice L; Ganguly S; Pingali SR
    Ann Hematol; 2023 Oct; 102(10):2753-2763. PubMed ID: 37422592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the GMALL-B-ALL/NHL2002 protocol in Burkitt leukemia/lymphoma and aggressive non-Hodgkin-lymphomas with or without CNS involvement.
    Sakarou M; Eisele L; Dührsen U; Hüttmann A
    Eur J Haematol; 2019 Mar; 102(3):241-250. PubMed ID: 30471148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality and survival patterns of childhood lymphomas: geographic and age-specific patterns in Southern-Eastern European and SEER/US registration data.
    Karalexi MA; Georgakis MK; Dessypris N; Ryzhov A; Zborovskaya A; Dimitrova N; Zivkovic S; Eser S; Antunes L; Sekerija M; Zagar T; Bastos J; Demetriou A; Agius D; Florea M; Coza D; Bouka E; Dana H; Hatzipantelis E; Kourti M; Moschovi M; Polychronopoulou S; Stiakaki E; Pourtsidis A; Petridou ET
    Hematol Oncol; 2017 Dec; 35(4):608-618. PubMed ID: 27641612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second primary cancers in non-Hodgkin lymphoma: Family history and survival.
    Chattopadhyay S; Zheng G; Sud A; Sundquist K; Sundquist J; Försti A; Houlston R; Hemminki A; Hemminki K
    Int J Cancer; 2020 Feb; 146(4):970-976. PubMed ID: 31054153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric Burkitt lymphoma is a distinct subtype that has superior outcomes to other types of Burkitt lymphoma/leukemia.
    Park YH; Kim WS; Kang HJ; Na II; Ryoo BY; Yang SH; Lee SS; Uhm JE; Kim K; Jung CW; Park K; Ko YH
    Ann Hematol; 2006 May; 85(5):285-90. PubMed ID: 16518604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presentation and Outcomes of Childhood Cancer Patients at Uganda Cancer Institute.
    Mutyaba I; Wabinga HR; Orem J; Casper C; Phipps W
    Glob Pediatr Health; 2019; 6():2333794X19849749. PubMed ID: 31205984
    [No Abstract]   [Full Text] [Related]  

  • 10. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
    Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
    JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
    Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
    [No Abstract]   [Full Text] [Related]  

  • 12. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M; Chen BE; Jaffe ES; Travis LB
    J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased incidence of a second lymphoproliferative malignancy in patients with multiple myeloma--a SEER based study.
    Chakraborty S; Hauke RJ; Bonthu N; Tarantolo SR
    Anticancer Res; 2012 Oct; 32(10):4507-15. PubMed ID: 23060579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study.
    Galicier L; Fieschi C; Borie R; Meignin V; Daniel MT; Gérard L; Oksenhendler E
    Blood; 2007 Oct; 110(8):2846-54. PubMed ID: 17609431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival predictors of Burkitt's lymphoma in children, adults and elderly in the United States during 2000-2013.
    Mukhtar F; Boffetta P; Risch HA; Park JY; Bubu OM; Womack L; Tran TV; Zgibor JC; Luu HN
    Int J Cancer; 2017 Apr; 140(7):1494-1502. PubMed ID: 28006853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in survival of patients with stage I/II Burkitt lymphoma in the United States: A SEER database analysis.
    Liu ZL; Liu PP; Bi XW; Lei DX; Wang Y; Li ZM; Jiang WQ; Xia Y
    Cancer Med; 2019 Mar; 8(3):874-881. PubMed ID: 30706675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second Primary Cancers in Melanoma Patients Critically Shorten Survival.
    Zheng G; Chattopadhyay S; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki K
    Clin Epidemiol; 2020; 12():105-112. PubMed ID: 32158273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burkitt lymphoma (BL): reclassification of 39 lymphomas diagnosed as BL or Burkitt-like lymphoma in the past based on immunohistochemistry and fluorescence in situ hybridization.
    Kodet R; Mrhalová M; Stejskalová E; Kabícková E
    Cesk Patol; 2011 Jul; 47(3):106-14. PubMed ID: 21887927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of p-AKT and p-mTOR in pediatric Burkitt lymphoma and their correlation with prognosis].
    Man J; Chen L; Zhai XW; Ma YY; Wang HS; Qian XW; Feng JY; Zhao J; Cao P; Lu FJ
    Zhonghua Bing Li Xue Za Zhi; 2020 Feb; 49(2):156-161. PubMed ID: 32074729
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.
    Bürgesser MV; Gualco G; Diller A; Natkunam Y; Bacchi CE
    Ann Diagn Pathol; 2013 Jun; 17(3):250-5. PubMed ID: 23246412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.